Long‐acting cabotegravir and rilpivirine in people with <scp>HIV</scp> and obesity: Real‐world outcomes from the <scp>RELATIVITY</scp> cohort

In this real-world cohort, LAI CAB + RPV was safe and effective in PWH with obesity, with comparable VF rates, tolerability, and adherence to participants without obesity. These findings support the use of LAI CAB + RPV across diverse PWH populations, including those with a BMI ≥ 30 kg/m<sup>2</sup>, and highlight its feasibility in PWH with multiple comorbidities.

Authors

Institutions

Publication Details

Journal
HIV Medicine
Published
2026-01-25
DOI
https://doi.org/10.1111/hiv.70196
Primary Topic
HIV-related health complications and treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Long‐acting cabotegravir and rilpivirine in people with HIV and obesity: Real‐world outcomes from the RELATIVITY cohort

Roberto Pedrero‐Tomé, Inmaculada Poquet, A. Carolina Rodríguez, Magdalena Muelas‐Fernandez et al.
HIV Medicine
HIV-related health complications and treatments
article

Long‐acting cabotegravir and rilpivirine in people with HIV and obesity: Real‐world outcomes from the RELATIVITY cohort

Roberto Pedrero‐Tomé, Inmaculada Poquet, A. Carolina Rodríguez, Magdalena Muelas‐Fernandez, Juan Carlos Gainzarain, Noemí Cabello‐Clotet, Cristina Escrich, Beatriz Valentín, María del Carmen Navarro, Alberto Romero, Francisco Redondo Tejerina, María Antonia Sepúlveda, Bárbara Alonso, Guillermo Soria, María del Carmen Montero, María Aguilera, M Alcaraz, María Ángeles Garcinuño, Lucia Yunquera Romero, Analuz Fernández, Juan José Corte, Jesús Troya, Víctor Arenas, Miriam Estébanez, Isabel Sanjoaquin, Alfonso Cabello, Rebeca Cabo, Mireia Cairó, Nuria Vázquez, Eva María Ferreira, José Sanz, Francisco Fanjul, Enrique Bernal, Luis Enrique Morano, Otilia Bisbal, Sara García, Ruth Caballero, Clara Martínez, Rafael Mican, Carmen Hidalgo‐Tenorio, Jara Llenas‐García, María Jesús Vivancos‐Gallego, Juan Emilio Losa‐García, Luis Buzón‐Martín, María José Galindo, Miguel Alberto de Zárraga, Claudia González‐Rico, María Luisa Montes
article en

Abstract

In this real-world cohort, LAI CAB + RPV was safe and effective in PWH with obesity, with comparable VF rates, tolerability, and adherence to participants without obesity. These findings support the use of LAI CAB + RPV across diverse PWH populations, including those with a BMI ≥ 30 kg/m<sup>2</sup>, and highlight its feasibility in PWH with multiple comorbidities.

HIV Medicine
Catholic University of Ávila (ES), Instituto Cajal (ES), Hospital Universitario de Canarias (ES), Hospital Universitario La Paz (ES), Instituto de Salud Carlos III (ES), Bellvitge University Hospital (ES), University Hospital Complex Of Vigo (ES), Hospital General Universitario Gregorio Marañón (ES), Hospital Clínico San Carlos (ES), Hospital General De Segovia (ES), Hospital Universitario San Agustín (ES), Hospital Son Llatzer (ES), Hospital Universitario de Torrejón (ES), Hospital General Universitario Morales Meseguer (ES), Hospital Universitario de Guadalajara (ES), Hospital Clínico Universitario de Valencia (ES), University Hospital Mútua de Terrassa (ES), Hospital de Viladecans (ES), Hospital Universitario Fundación Alcorcón (ES), Hospital Universitario 12 De Octubre (ES), Hospital La Paz Institute for Health Research (ES), Hospital Universitario Puerta de Hierro Majadahonda (ES), Hospital Doctor José Molina Orosa (ES), Hospital Universitario Príncipe de Asturias (ES), Fundación Hospital de Jove (ES), Hospital Universitario Araba (ES), Instituto de Investigación Marqués de Valdecilla (ES), Instituto de Investigación Biosanitaria de Granada (ES), Hospital Universitario Miguel Servet (ES), Corporació Sanitària Parc Taulí (ES), Hospital Universitario de Burgos (ES), Hospital General Universitario de Elche (ES), Hospital Universitario Virgen de las Nieves (ES), Hospital Santa Caterina (ES), Biomedical Research and Innovation Institute of Cadiz (ES), Hospital Universitario del Sureste (ES), Hospital Universitario Fundación Jiménez Díaz (ES), Mútua Terrassa (ES), Hospital Reina Sofía de Murcia (ES), Hospital Universitario de La Princesa (ES), Hospital Universitario Central de Asturias (ES), Hospital Clínico Universitario Lozano Blesa (ES), Hospital Universitario de Fuenlabrada (ES), Hospital Universitario De Cabueñes (ES), Hospital Universitari de Tortosa Verge de la Cinta (ES), Hospital Universitario Son Espases (ES), Hospital Marina Baixa (ES), Hospital Universitario Río Hortega (ES), INCLIVA Health Research Institute (ES), Complejo Hospitalario de Pontevedra (ES), Hospital Universitario Ramón y Cajal (ES), Complejo Hospitalario Universitario de Toledo (ES), Hospital Central de la Defensa Gómez Ulla (ES), Hospital Universitario Infanta Leonor (ES), Hospital Universitario de Toledo (ES), Universidad Autónoma de Madrid (ES)
Good health and well-being
Openalex Percentile: Top 80%
HIV-related health complications and treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.